Simplifying Global Compliance
FDAnews Drug Daily Bulletin
FDA Advisory Panel Skeptical on Up-Scheduling Hydrocodone
Jan. 28, 2013
The Drug Enforcement Agency (DEA) has asked for the FDA’s opinion on whether to reclassify hydrocodone from schedule III to the stricter schedule II category, but briefing documents show the agency is not sold on the idea.
Drug Industry Daily
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing